← Oncology Approval Tracker

FDA DECISION ·

Carfilzomib (Kyprolis first generic)

carfilzomib · Apotex

First generic approvalFirst genericMultiple myeloma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First generic Kyprolis 30 mg vial for patients with relapsed or refractory multiple myeloma after one to three prior lines of therapy.

LAMPGEN ANALYSIS

Why it matters

Added an approved generic presentation of the proteasome inhibitor.

What research teams should watch

Verify vial strength and product-specific labeling before updating preparation and inventory rules.

PRIMARY RECORDS

Sources